Safety and tolerability of sifalimumab, an anti-interferon-α monoclonal antibody, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study

Tsutomu Takeuchi, Yoshiya Tanaka, Ryutaro Matsumura, Kazuyoshi Saito, Mitsuhiro Yoshimura, Koichi Amano, Tatsuya Atsumi, Eiichi Suematsu, Nobuya Hayashi, Liangwei Wang, Raj Tummala

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Fingerprint Dive into the research topics of 'Safety and tolerability of sifalimumab, an anti-interferon-α monoclonal antibody, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study'. Together they form a unique fingerprint.

Medicine & Life Sciences